Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Soria

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced diseaseAlessandro Soria, Adriano Lazzarin
The New Microbiologica|July 11, 2007
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a reviewNicola Gianotti, Alessandro Soria, Adriano Lazzarin
AIDS (London, England)|June 23, 2026
Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIVGiuseppe Lapadula, Alessandro Soria, Massimo Puoti, et al.
Expert Review of Gastroenterology & Hepatology|May 14, 2019
Nonalcoholic fatty liver disease and steatohepatitis in people living with HIVNicola Squillace, Alessandro Soria, Giorgio Bozzi, et al.
BMC Pharmacology & Toxicology|October 2, 2014
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon αDavide Mangioni, Alessandro Soria, Laura Brighina, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
Plos One|January 28, 2021
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19Alessandro Soria, Stefania Galimberti, Giuseppe Lapadula, et al.
Journal of Medical Virology|April 23, 2008
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutationsAlessandro Soria, Mariangela Cavarelli, Stefania Sala, et al.
Plos One|February 12, 2015
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trialAlessandro Soria, Daria Trabattoni, Nicola Squillace, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 20, 2016
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-upMarco Ripa, Manuela Pogliaghi, Stefania Chiappetta, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced diseaseAlessandro Soria, Adriano Lazzarin
The New Microbiologica|July 11, 2007
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a reviewNicola Gianotti, Alessandro Soria, Adriano Lazzarin
AIDS (London, England)|June 23, 2026
Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIVGiuseppe Lapadula, Alessandro Soria, Massimo Puoti, et al.
Expert Review of Gastroenterology & Hepatology|May 14, 2019
Nonalcoholic fatty liver disease and steatohepatitis in people living with HIVNicola Squillace, Alessandro Soria, Giorgio Bozzi, et al.
BMC Pharmacology & Toxicology|October 2, 2014
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon αDavide Mangioni, Alessandro Soria, Laura Brighina, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
Plos One|January 28, 2021
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19Alessandro Soria, Stefania Galimberti, Giuseppe Lapadula, et al.
Journal of Medical Virology|April 23, 2008
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutationsAlessandro Soria, Mariangela Cavarelli, Stefania Sala, et al.
Plos One|February 12, 2015
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trialAlessandro Soria, Daria Trabattoni, Nicola Squillace, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 20, 2016
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-upMarco Ripa, Manuela Pogliaghi, Stefania Chiappetta, et al.
Pageof 6